本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Ocular Therapeutix

11.03
-0.0500-0.45%
盤後11.030.00000.00%19:38 EDT
成交量:213.25萬
成交額:2,373.96萬
市值:17.57億
市盈率:-9.59
高:11.31
開:10.85
低:10.76
收:11.08
資料載入中...
2024/07/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/17

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/06/14

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/18

重要事件披露

Form 8-K - Current report
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/28

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]